CNE000000X38
CNE000000X38
SHANGHAI FOSUN PHARMACEUTICAL G
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 63.8B EUR | 71.11B EUR |
Enterprise Value | 100.79B EUR | 97.58B EUR |
Valuation Multiples | ||
Trailing P/E | 18.66x | 20.79x |
Forward P/E | 21.72x | -- |
Price to Sales | 1.5x | 1.7x |
Price to Book | 1.29x | 1.45x |
EV/Revenue | 2.37x | 2.33x |
EV/EBITDA | 17.08x | 14.67x |
Price to FCF (P/FCF) | 28.22x | 106.32x |
EV/FCF | 44.59x | 145.89x |
FCF Yield | 3.54% | 0.94% |